Blockchain Registration Transaction Record
TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board
TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board, enhancing its cancer therapy programs. The addition of Dr. Zamore underscores the company's commitment to developing innovative RNA therapeutics for metastatic disease.

This news matters as it highlights a strategic move by TransCode Therapeutics to strengthen its cancer therapy programs with the expertise of Dr. Zamore. The addition of such a prominent figure in RNA research signifies the company's commitment to advancing innovative RNA therapeutics for the treatment of metastatic disease, potentially offering new hope for cancer patients.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x7c1235fbb6c3c9f9be684d408d72c50995f7e935b3251df85b82816a495a077c |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | elleVXCO-7ecf91e8454bb81c714e30372f6b2277 |